Asymchem Laboratories (Tianjin) Management
Management criteria checks 2/4
Asymchem Laboratories (Tianjin)'s CEO is Hao Hong, appointed in Jan 2022, has a tenure of 2.92 years. directly owns 4.02% of the company’s shares, worth CN¥1.08B. The average tenure of the management team and the board of directors is 2.9 years and 13.4 years respectively.
Key information
Hao Hong
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 2.9yrs |
CEO ownership | 4.0% |
Management average tenure | 2.9yrs |
Board average tenure | 13.4yrs |
Recent management updates
Recent updates
Earnings Troubles May Signal Larger Issues for Asymchem Laboratories (Tianjin) (SZSE:002821) Shareholders
Nov 05Estimating The Intrinsic Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)
Oct 15Investors Still Aren't Entirely Convinced By Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Earnings Despite 25% Price Jump
Sep 28Is There An Opportunity With Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) 49% Undervaluation?
Jul 16Asymchem Laboratories (Tianjin) (SZSE:002821) Is Paying Out A Dividend Of CN¥1.80
Jun 27Benign Growth For Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Underpins Its Share Price
Jun 26Does Asymchem Laboratories (Tianjin) (SZSE:002821) Have A Healthy Balance Sheet?
May 22Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Just Missed Earnings: Here's What Analysts Think Will Happen Next
Apr 03Downgrade: Here's How Analysts See Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) Performing In The Near Term
Apr 02A Look At The Fair Value Of Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821)
Mar 26Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Mar 04CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | CN¥769m |
Jun 30 2024 | n/a | n/a | CN¥1b |
Mar 31 2024 | n/a | n/a | CN¥2b |
Dec 31 2023 | n/a | n/a | CN¥2b |
Sep 30 2023 | n/a | n/a | CN¥3b |
Jun 30 2023 | n/a | n/a | CN¥3b |
Mar 31 2023 | n/a | n/a | CN¥3b |
Jan 01 2023 | n/a | n/a | CN¥3b |
Sep 30 2022 | n/a | n/a | CN¥3b |
Jun 30 2022 | n/a | n/a | CN¥2b |
Mar 31 2022 | n/a | n/a | CN¥1b |
Dec 31 2021 | CN¥2m | CN¥2m | CN¥1b |
Sep 30 2021 | n/a | n/a | CN¥908m |
Jun 30 2021 | n/a | n/a | CN¥830m |
Mar 31 2021 | n/a | n/a | CN¥766m |
Dec 31 2020 | CN¥2m | CN¥2m | CN¥719m |
Sep 30 2020 | n/a | n/a | CN¥694m |
Jun 30 2020 | n/a | n/a | CN¥640m |
Mar 31 2020 | n/a | n/a | CN¥570m |
Dec 31 2019 | CN¥2m | n/a | CN¥554m |
Compensation vs Market: Insufficient data to establish whether Hao's total compensation is reasonable compared to companies of similar size in the CN market.
Compensation vs Earnings: Hao's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Hao Hong (68 yo)
2.9yrs
Tenure
CN¥9,152,000
Compensation
Dr. Hao Hong, Ph D serves as the Chief Executive Officer of Asymchem Life Science (Tianjin) Co. Ltd. Dr. Hong serves as Chairman, Chief Executive Officer and President of Asymchem Laboratories, Inc. Dr. Ho...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 2.9yrs | CN¥9.15m | 4.02% CN¥ 1.1b | |
Co-CEO & Executive Director | 2.9yrs | CN¥6.64m | no data | |
CFO, Senior VP & Executive Director | 6.3yrs | CN¥5.88m | 0.071% CN¥ 19.0m | |
Executive VP & Executive Director | 2.9yrs | CN¥3.54m | 0.0056% CN¥ 1.5m | |
CTO & CBO | 1.8yrs | no data | no data | |
Chief Scientific Officer | 2.9yrs | CN¥2.29m | no data | |
Executive Vice President | 2.9yrs | CN¥665.70k | 0.025% CN¥ 6.8m | |
Senior Vice President of Business Development | no data | no data | no data | |
Senior Vice President of Process Development | no data | CN¥1.58m | no data | |
Senior Vice President of 5S Management | no data | no data | no data | |
Executive Vice President | 2.9yrs | no data | 0.091% CN¥ 24.4m | |
Senior Vice President of Process Development & Application | 6.9yrs | no data | no data |
2.9yrs
Average Tenure
48.5yo
Average Age
Experienced Management: 002821's management team is considered experienced (2.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 13.4yrs | CN¥9.15m | 4.02% CN¥ 1.1b | |
Co-CEO & Executive Director | 13.4yrs | CN¥6.64m | no data | |
CFO, Senior VP & Executive Director | 5.7yrs | CN¥5.88m | 0.071% CN¥ 19.0m | |
Executive VP & Executive Director | 13.4yrs | CN¥3.54m | 0.0056% CN¥ 1.5m | |
Non-Executive Director | 13.4yrs | CN¥752.00k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Non Executive Director | 3.5yrs | CN¥128.00k | no data | |
Chairman of the Supervisory Committee | 13.4yrs | no data | no data | |
Non-Executive Director | 3.8yrs | CN¥1.93m | 0.00087% CN¥ 234.1k | |
Member of Scientific Advisory Board | no data | no data | no data |
13.4yrs
Average Tenure
46yo
Average Age
Experienced Board: 002821's board of directors are seasoned and experienced ( 13.4 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/20 16:28 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Asymchem Laboratories (Tianjin) Co., Ltd. is covered by 27 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Bo Li | BofA Global Research |
Yue Gao | Changjiang Securities Co. LTD. |
Hao Wu | Chasing Securities |